Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» vaccines
vaccines
Valneva joins the phase 3 Covid-19 vaccine club
EP Vantage
Thu, 04/22/21 - 10:47 am
Valneva
VLA2001
vaccines
COVID-19
clinical trials
Ocugen
Covaxin
Pfizer and BioNTech Vaccine Sales Jump $1.4 Billion Thanks to AstraZeneca's Blunders
Motley Fool
Thu, 04/22/21 - 10:44 am
Pfizer
BioNTech
Europe
AstraZeneca
vaccines
COVID-19
With demand uncertain and its U.S. manufacturing in limbo, AstraZeneca still aims to seek FDA nod for COVID-19 vaccine
Fierce Pharma
Wed, 04/21/21 - 11:24 pm
AstraZeneca
COVID-19
vaccines
FDA
Emergency Use Authorization
As fears mount over J&J and AstraZeneca, Novavax enters a shaky spotlight
Endpoints
Wed, 04/21/21 - 11:20 pm
JNJ
AstraZeneca
Novavax
vaccines
COVID-19
Johnson & Johnson to resume Covid-19 vaccine roll-out in Europe after EMA review
Pharmaceutical Business Review
Wed, 04/21/21 - 10:38 am
JNJ
vaccines
COVID-19
Europe
blood clots
FDA offers scathing review of Emergent plant's sanitary conditions, employee training after halting production
Endpoints
Wed, 04/21/21 - 10:36 am
FDA
Emergent BioSolutions
regulatory inspections
drug manufacturing
vaccines
U.S. CDC expands COVID-19 vaccine eligibility to 16 and older
Reuters
Wed, 04/21/21 - 10:32 am
COVID-19
vaccines
CDC
The next 2 months in biotech and pharma will be busy. Here's what to watch.
BioPharma Dive
Tue, 04/20/21 - 11:16 pm
Biogen
aducanumab
FDA
Vertex Pharmaceuticals
Sarepta Therapeutics
JNJ
AstraZeneca
vaccines
COVID-19
A top analyst sees Pfizer and Moderna seizing a $38B prize as safety frets sideline global vaccine players
Endpoints
Tue, 04/20/21 - 11:10 am
Pfizer
Moderna Therapeutics
COVID-19
vaccines
JNJ
AstraZeneca
How Johnson & Johnson Beat Expectations in Q1
Motley Fool
Tue, 04/20/21 - 11:09 am
JNJ
earnings
COVID-19
vaccines
EMA to add safety warning to J&J Covid-19 vaccine over rare blood clots
Endpoints
Tue, 04/20/21 - 10:58 am
EMA
Europe
JNJ
vaccines
blood clots
COVID-19
Half of US adults have received at least one COVID-19 vaccine dose
Beckers Hospital Review
Mon, 04/19/21 - 10:26 pm
vaccines
COVID-19
Serum Institute nears $400M grant to boost AstraZeneca COVID shot production—just as material shortages mount
Fierce Pharma
Mon, 04/19/21 - 10:19 pm
Serum Institute
AstraZeneca
COVID-19
vaccines
Fauci Says J&J Vaccine Likely to Resume by Friday
BioSpace
Mon, 04/19/21 - 10:18 pm
JNJ
vaccines
COVID-19
Anthony Fauci
The Moderna CEO's Bold Statement That May Mean Bad News for Novavax
Motley Fool
Mon, 04/19/21 - 11:23 am
Moderna Therapeutics
Novavax
Pharma CEOs
vaccines
COVID-19
Stephane Bancel
flu vaccines
FDA orders shutdown at Emergent's troubled plant 2 weeks after handing J&J the keys
Fierce Pharma
Mon, 04/19/21 - 11:16 am
Emergent BioSolutions
drug manufacturing
vaccines
FDA
COVID-19
South African variant may 'break through' Pfizer vaccine protection, but vaccine highly effective, Israeli study says
Yahoo/Reuters
Sun, 04/18/21 - 11:35 pm
COVID-19
Pfizer
vaccines
BioNTech
COVID-19 variants
Moderna cuts COVID-19 vaccine deliveries to Canada, U.K. amid European supply struggles
Fierce Pharma
Sun, 04/18/21 - 12:07 am
Moderna Therapeutics
vaccines
COVID-19
UK
Canada
Europe
Pfizer CEO: Third COVID-19 Vaccine Dose Will Likely Be Needed Within 12 Months
BioSpace
Fri, 04/16/21 - 09:59 am
Pfizer
vaccines
COVID-19
Albert Bourla
Pharma CEOs
Johnson & Johnson asked rival COVID-19 vaccine makers to probe clotting risks
Yahoo/Reuters
Fri, 04/16/21 - 09:47 am
JNJ
Pfizer
BioNTech
Moderna Therapeutics
blood clots
vaccines
COVID-19
Pages
« first
‹ previous
…
75
76
77
78
79
80
81
82
83
…
next ›
last »